Page last updated: 2024-08-18

xanthenes and Anxiety

xanthenes has been researched along with Anxiety in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19908 (72.73)18.7374
1990's0 (0.00)18.2507
2000's1 (9.09)29.6817
2010's2 (18.18)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alexander, L; Cardinal, RN; Clarke, HF; Cockcroft, GJ; Dalley, JW; Quah, SKL; Roberts, AC; Santangelo, AM; Shiba, Y; Wallis, CU; Xia, J; Zeredo, JL1
Bespalov, AY; Gross, G; Mezler, M; Schoemaker, H; Sukhotina, IA; van Gaalen, MM; Wicke, K1
Bouwalerh, H; Maccari, S; Mairesse, J; Marrocco, J; Morley-Fletcher, S; Ngomba, RT; Nicoletti, F; Pittaluga, A; Silletti, V; Summa, M; Van Camp, G1
Ciurezu, T; Predescu, V; Roman, I; Timofte, G1
Butler Blacker, A1
Nikolovski, OT; Simeon, J; Spero, M1
Raskin, DE1
Webb, WL1
Bovi, A1
Mariategui, J; Raab, ES1

Trials

4 trial(s) available for xanthenes and Anxiety

ArticleYear
Symptomatic relief with flupentixol (Fluanxol) of the anxious-algetic-depressive syndrome complex in neurotic states. A double-blind, placebo-controlled study.
    Acta psychiatrica Scandinavica, 1973, Volume: 49, Issue:1

    Topics: Adult; Age Factors; Ambulatory Care; Anxiety; Clinical Trials as Topic; Depression; Drug Tolerance; Ethanol; Evaluation Studies as Topic; Female; Humans; Male; Middle Aged; Neurotic Disorders; Pain; Piperazines; Placebos; Sex Factors; Syndrome; Tranquilizing Agents; Xanthenes

1973
Psychopharmacology.
    Acta psychiatrica Scandinavica. Supplementum, 1970, Volume: 217

    Topics: Alcoholism; Anxiety; Brain Damage, Chronic; Chronic Disease; Clinical Trials as Topic; Depression; Ethanol; Humans; Injections, Intramuscular; Meprobamate; Phenothiazines; Piperazines; Propranolol; Psychopharmacology; Reserpine; Retinitis; Schizophrenia; Thioridazine; Trifluoperazine; Xanthenes

1970
[Therapeutic trial with thiothixene in emotional disorders. Controlled study and use of new forms of evaluation].
    Revista de neuro-psiquiatria, 1969, Volume: 32, Issue:2

    Topics: Anxiety; Clinical Trials as Topic; Evaluation Studies as Topic; Female; Humans; Male; Neurotic Disorders; Placebos; Thiothixene; Tranquilizing Agents; Xanthenes

1969
Thiothixene in the treatment of anxiety and depression in outpatients.
    Current therapeutic research, clinical and experimental, 1970, Volume: 12, Issue:6

    Topics: Adult; Anxiety; Depression; Female; Humans; Male; Middle Aged; Placebos; Procyclidine; Xanthenes

1970

Other Studies

7 other study(ies) available for xanthenes and Anxiety

ArticleYear
Glutamate Within the Marmoset Anterior Hippocampus Interacts with Area 25 to Regulate the Behavioral and Cardiovascular Correlates of High-Trait Anxiety.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2019, 04-17, Volume: 39, Issue:16

    Topics: Amino Acids; Animals; Anxiety; Behavior, Animal; Benzylamines; Callithrix; Excitatory Amino Acid Antagonists; Female; GABA-A Receptor Antagonists; Glutamic Acid; Heart Rate; Hippocampus; Male; Phosphinic Acids; Xanthenes

2019
Behavioral characterization of the mGlu group II/III receptor antagonist, LY-341495, in animal models of anxiety and depression.
    European journal of pharmacology, 2008, Sep-11, Volume: 592, Issue:1-3

    Topics: Amino Acids; Amphetamine; Animals; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Anxiety; Behavior, Animal; Central Nervous System Stimulants; Conditioning, Operant; Darkness; Depression; Diazepam; Fever; Fluoxetine; Light; Male; Mice; Paroxetine; Receptors, Metabotropic Glutamate; Reinforcement Schedule; Stress, Psychological; Xanthenes

2008
Anxiety-like behavior of prenatally stressed rats is associated with a selective reduction of glutamate release in the ventral hippocampus.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2012, Nov-28, Volume: 32, Issue:48

    Topics: Amino Acids; Animals; Anxiety; Behavior, Animal; Benzylamines; Excitatory Amino Acid Antagonists; Female; GABA-A Receptor Antagonists; Glutamic Acid; Hippocampus; Kainic Acid; Male; Munc18 Proteins; Phosphinic Acids; Pregnancy; Prenatal Exposure Delayed Effects; R-SNARE Proteins; rab3A GTP-Binding Protein; Rats; Rats, Sprague-Dawley; Seizures; Stress, Psychological; Synapsins; Synaptic Transmission; Synaptophysin; Syntaxin 1; Xanthenes

2012
Akathisia: a side effect to be remembered.
    The American journal of psychiatry, 1972, Volume: 129, Issue:3

    Topics: Antiparkinson Agents; Anxiety; Barbiturates; Basal Ganglia Diseases; Butyrophenones; Humans; Hyperkinesis; Mental Disorders; Movement Disorders; Phenothiazines; Tranquilizing Agents; Xanthenes

1972
The use of psychopharmacological drugs in the aged.
    Geriatrics, 1971, Volume: 26, Issue:6

    Topics: Affective Symptoms; Aged; Antidepressive Agents; Anxiety; Barbiturates; Butyrophenones; Dementia; Desipramine; Dextroamphetamine; Diazepam; Humans; Imipramine; Isocarboxazid; Mental Disorders; Monoamine Oxidase Inhibitors; Nortriptyline; Phenelzine; Phenothiazines; Phytotherapy; Piperazines; Plants, Medicinal; Rauwolfia; Thiothixene; Tranquilizing Agents; Tranylcypromine; Xanthenes

1971
[Clinical tests of the anxiolytic effect of clopenthixol in small doses].
    Giornale di psichiatria e di neuropatologia, 1970, Volume: 98, Issue:3-4

    Topics: Anxiety; Anxiety Disorders; Clopenthixol; Dysautonomia, Familial; Humans; Neurasthenia; Piperazines; Tranquilizing Agents; Xanthenes

1970
[Thiothixene in ambulatory treatment of emotional disorders. Preliminary evaluation].
    Revista de neuro-psiquiatria, 1968, Volume: 31, Issue:2

    Topics: Adult; Affective Symptoms; Ambulatory Care; Anxiety; Depression; Humans; Male; Middle Aged; Thiothixene; Tranquilizing Agents; Xanthenes

1968